Investments
Cambridge Fintech Stars Take Centre Stage at Cambridge Independent Science and Technology Awards
London and Cambridge (UK), May 2026: Two of Cambridge’s leading fintech innovators, AlgoDynamix and SyndicateRoom, received major recognition at the recent Cambridge Independent Science and Technology Awards, held at the prestigious Genome Campus at Hinxton Hall. ...
Cambridge Science Park submits masterplan to unlock the region's potential
Cambridge Science Park submits its masterplan for planning consent, continuing its commitment to a site that has been a cornerstone of the Cambridge phenomenon over the past 50 years. The plan is entirely privately funded, increasing built space from 2.8 million to approximately 8 milli...
Alfa Corporate Finance advises on the sale of Cambridge based Blue Scientific to Aptco Group
Alfa Corporate Finance has advised on the sale of BlueScientific to Aptco Group, supporting the shareholders from initial strategic review through to buyer selection, negotiation and completion. The transaction enables BlueScientific to join a broader pan-European platform while retaini...
A weekend in Cambridge - Exclusive for families and partners of The University Arms and Cambridge Network
University Arms Cambridge is opening its doors to the families and guests of our corporate partners. Indulge with 30% off B&B on Friday, Saturday, and Sunday nights, a welcome drink on arrival, and breakfast included. Available by invitation only. Email [email protected] to...
Cambridge Index advances 1.8%
The Cambridge Index climbed 472.1 points or 1.8% to close at 27,215.7, as six out of the top ten index heavyweights posted weekly gains in their share price. ...
AVEVA to invest c.£30million in Cambridge Research and Development hub to support future growth
Global industrial software leader to consolidate its Cambridge teams at Science Park global HQ ahead of a 2027 opening, reinforcing its long-term commitment to the city and its Industrial Intelligence strategy. ...
Daniel Zeichner MP welcomes Astrazeneca’s £300 million investment as boost for Cambridge
Daniel Zeichner, MP for Cambridge, has welcomed the announcement made by the Prime Minister, Sir Keir Starmer, during Prime Minister’s Questions today that AstraZeneca will invest £300 million into the UK’s life sciences sector. ...
12 gene therapies converge on retinitis pigmentosa and a $3.4bn market by 2033
This month Gene Scope Intelligence (www.genescope-intelligence.com), a dedicated gene therapy market intelligence platform releases a brand new commercial analysis and demand forecast for new gene therapies directed at Retinitis Pigmentosa (RP). ...
The Common Thread — Monthly Networking Morning
Kickstart your day by connecting with brilliant people and opening doors to new opportunities.Join us at University Arms, in collaboration with the wonderful Neil Bharadwa at The Cambridge Fruit Company, for The Common Thread. A relaxed monthly networking morning bringing together Cambr...
Book launch: 'Research Handbook on Corporate Psychopaths'
Introducing the novel theory of corporate psychopathy, the Research Handbook defines and measures the characteristics, behaviours, and impacts of psychopathic individuals from a personal to a societal scale. This unique book presents theoretical, multidisciplinary and applied research i...